Dr. Costas Pitsillides (PhD), is a visiting research fellow at CUT. He has significant expertise in preclinical imaging and drug development as his PhD work was on the design of biomedical imaging systems for disease monitoring at the Massachusetts General Hospital, Harvard Medical School, and Boston University in the US. He also holds graduate degrees from the Massachusetts Institute of Technology and an undergraduate degree from Northeastern University, where he studied Physics on a Fulbright Scholarship. He joined CUT as a Marie Curie Fellow in 2010, where he has been developing the university’s preclinical research labs; he has designed and built several optical based systems for in vivo applications and has in parallel served as a scientific and business development adviser with several Cyprus-based companies such as Trojantec and Curis Life Sciences. He co-founded Theramir, a cancer therapeutics company, in 2016, as well as Promed Bioscience, a company developing novel collagen-based biomaterials, in 2017. His areas of interest include novel in vivo imaging systems and advanced applications of biomaterials and nanotechnology in medicine.